adaptive biotechnologies stock analysis

Adaptive Biotechnologies Corporation is a commercial-stage company. Sentiment uses short term technical analysis to gauge whether a stock is desired by investors.

Goldman Sachs These 2 Stocks Are Poised To Surge By At Least 30 Nasdaq

Down from US1625 the current price target is an average from 8 analysts.

. Ad See how Invesco QQQ ETF can fit into your portfolio. Wide Range Of Investment Choices Including Options Futures and Forex. As a technical indicator it focuses on recent trends as opposed to the long term.

Detailed balance sheet for Adaptive Biotechnologies ADPT including cash debt assets liabilities and book value. Access the Nasdaqs Largest 100 non-financial companies in a Single Investment. The 7 analysts offering 12-month price forecasts for Adaptive Biotechnologies.

Ad Key clinical and regulatory developments could kickstart biotech investments. Ad Our Strong Track Record Has Enabled Us To Become A Leader In Rare Disease. View todays Adaptive Biotechnologies Corp stock price and latest ADPT news and analysis.

See Adaptive Biotechnologies Corporation ADPT stock analyst estimates including earnings and revenue EPS upgrades and downgrades. Stock Price Forecast. According to 15 stock analysts the average 12-month stock price forecast for ADPT stock is 1343 which predicts an increase of 8783.

10393 Upside Based on 4 Wall Street analysts offering 12 month price targets for Adaptive Biotechnologies in the last 3 months. Find the latest Adaptive Biotechnologies Corporation ADPT stock analysis from Seeking Alphas top analysts. ADPTs market cap has decreased by.

Access the Nasdaqs Largest 100 non-financial companies in a Single Investment. ADPT Stock Price Prediction. New target price is 27 above last closing price of US1145.

Exclusive research and insights from bulls and bears. Adaptive Biotechnologies Stock analysis including Adaptive Biotechnologies investment evaluation stock information alerts predictive tools such as market volatility and liquidity. Adaptive Biotechnologies Corporation has a market cap of 121 billion and is expected to release its quarterly earnings report on Feb 22 2022 Feb 28 2022.

Create real-time notifications to follow any changes in the live stock price. Real time Adaptive Biotechnologies Corporation ADPT stock price quote stock graph news analysis. Price target decreased to US1458.

As of the 3rd of April Adaptive Biotechnologies shows the risk adjusted performance of 013 and Mean Deviation of 435Adaptive Biotechnologies technical analysis gives you the. Learn about growth drivers. Adaptive Biotechnologies ADPT.

A high-level overview of Adaptive Biotechnologies Corporation ADPT stock. Ad See how Invesco QQQ ETF can fit into your portfolio. Major clinical catalysts could push momentum in biotech.

ADPT Adaptive Biotechnologies - Stock quote performance technical chart analysis SmartSelect Ratings Group Leaders and the latest company headlines. The best long-term short-term Adaptive Biotechnologies share price prognosis for 2021 2022. ADPT has a market cap or net worth of 93153 million as of September 27 2022 making it the 2505th biggest public company in the US.

The Company is focused on using the biology of the adaptive. We Are Well Positioned to Deliver Sustainable Top-Tier Growth Enhanced Shareholder Value. Stay up to date on the latest stock price chart news analysis fundamentals trading and.

Adpt 10k 20201231 Htm